Activity Overview

This educational activity is an archive of the live conference held on March 13-14, 2026.

Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with GU malignancies. Urologists, fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, nuclear medicine physicians, and other health care professionals interested in the treatment of GU malignancies may also participate.

Learning Objectives

Integrate emerging therapies with multidisciplinary strategies to optimize treatment sequencing and coordination across specialties
Interpret advanced diagnostic and molecular testing strategies—including ctDNA and genomic profiling—for risk stratification and disease monitoring in GU malignancies

GET STARTED WITH THIS PROGRAM:

Create Account Already Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC designates this enduring material for a maximum of 3.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource^®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 3.50 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Exact Sciences Corporation and Exelixis, Inc.

Module 2: Prostate Cancer (II)

Maha Hussain, MD, FACP, FASCO

Cora N. Sternberg, MD, FACP

Daniel P. Petrylak, MD

Susan F. Slovin, MD, PhD

Sandy Srinivas, MD

Matthew R. Smith, MD, PhD

Scott T. Tagawa, MD, MS, FASCO, FACP

Steven Eric Finkelstein, MD, DABR, FACRO

Oliver Sartor, MD

GET STARTED WITH THIS PROGRAM:

You Also Might Like...